Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
NEOthis companyNeoGenomics, Inc.	$17.33	-14×	1.8×	2.07×	-15.87×	-168.7%	38.8%	-9.1%	-14.9%	-12.9%	-5.1%	-1.4%	0.56×	-8.08×	-17.61×	4.26×	0.0%	4	2.5	1	C-
BDSXBiodesix, Inc.	$8.23	-1.46×	-20.83×	0.58×	-4.79×	-1313.6%	81.1%	-31.4%	-39.8%	1430.6%	-38.9%	-46.1%	-29.56×	-2.45×	-3.6×	1.86×	0.0%	4	-5.55	1	D+
CSTLCastle Biosciences, Inc.	$33.23	-46.87×	2.39×	3.28×	92.37×	-640.8%	79.4%	-12.4%	-7.0%	-5.1%	-6.8%	2.5%	0.08×	-7.04×	-497.79×	5.26×	0.0%	3	7.56	2	B-
FRFRNMFreenome, Inc.	$10.93	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
GHGuardant Health, Inc.	$160.18	-30.77×	-128.95×	13.04×	-37.81×	-214.8%	64.5%	-44.5%	-42.4%	419.2%	-25.1%	-1.8%	-17.22×	-3.56×	-112.2×	4.84×	0.0%	4	4.87	2	C
GRALGRAIL Inc.	$131.06	-7.7×	1.22×	21.37×	-7.92×	-125.0%	-42.5%	-363.0%	-277.5%	-15.8%	-14.3%	-9.5%	0.04×	0.4×	0×	11.97×	0.0%	4	7.44	2	C+
Peer median	—	-19.23×	-9.81×	8.16×	-6.36×	-427.8%	71.9%	-37.9%	-41.1%	207.0%	-19.7%	-5.7%	-8.59×	-3.01×	-57.9×	5.05×	0.0%	4	6.15	2	—